Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred B Stock [Member]
Preferred C Stock [Member]
Common Stock [Member]
Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 24 $ 239,256 $ (234,078) $ 5,202
Balance, shares at Dec. 31, 2019 249 2,434,009      
Stock based compensation        
Extinguishment of derivative liability upon exercise of warrant $ 32 1,525   1,557
Extinguishment of derivative liability upon exercise of warrant, shares 3,128,895      
Issuance of common stock from the exercise of warrants for cash      
Issuance of common stock from the exercise of warrants for cash, shares 100      
Issuance of common stock from the cashless exercise of warrants        
Issuance of common stock from the cashless exercise of warrants, shares        
Preferred stock issued for cash   3,112   3,112
Preferred stock issued for cash, shares 9,440        
Common stock issued on conversion of preferred stock $ 62 (62)    
Common stock issued on conversion of preferred stock, shares (9,208) 6,215,742      
Issuance of agent warrants   168   168
Beneficial conversion feature on issuance of convertible preferred stock   3,111   3,111
Deemed dividend related to the issuance of preferred stock   (3,111)   (3,111)
Accretion of convertible preferred stock discount   6,173   6,173
Deemed dividend related to the conversion of preferred stock   (6,173)   (6,173)
Net income loss         1,169 1,169
Balance at Mar. 31, 2020 $ 118 243,999 (232,909) 11,208
Balance, shares at Mar. 31, 2020 249 232 11,778,746      
Balance at Dec. 31, 2020 $ 245 266,666 (241,107) 25,804
Balance, shares at Dec. 31, 2020 26 51 24,552,409      
Stock based compensation       36   36
Extinguishment of derivative liability upon exercise of warrant       195   195
Issuance of common stock from the exercise of warrants for cash     $ 2 194   196
Issuance of common stock from the exercise of warrants for cash, shares     130,275      
Issuance of common stock from the cashless exercise of warrants, shares     1,890      
Net income loss         (2,633) (2,633)
Balance at Mar. 31, 2021 $ 274 $ 267,091 $ (243,740) $ 23,598
Balance, shares at Mar. 31, 2021 26 51 24,684,574